A

Acusphere Inc
OTC:ACUS

Watchlist Manager
Acusphere Inc
OTC:ACUS
Watchlist
Price: 0 USD Market Closed
Market Cap: 0 USD

Operating Margin

-1 582.4%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 582.4%
=
Operating Income
$-42.5m
/
Revenue
$2.7m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 582.4%
=
Operating Income
$-42.5m
/
Revenue
$2.7m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Acusphere Inc
OTC:ACUS
495.1 USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
274.9B CHF
Loading...
CH
Novartis AG
SIX:NOVN
219.9B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.8B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
276.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.2B USD
Loading...
No Stocks Found

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 14 112 companies
5th percentile
-1 582.4%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Acusphere Inc
Glance View

Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The firm has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).

ACUS Intrinsic Value
Not Available
A
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 582.4%
=
Operating Income
$-42.5m
/
Revenue
$2.7m
How has Operating Margin changed over time?

Over the last 3 years, Acusphere Inc’s Operating Margin has decreased from -1 346.6% to -1 582.4%. During this period, it reached a low of -3 890% on Mar 31, 2007 and a high of -1 346.6% on Dec 1, 2005.

Back to Top